108 Participants Needed

ReACT for Functional Seizures

AF
Overseen ByAaron Fobian, PhD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores two therapy approaches to help young people with functional seizures, which resemble epileptic seizures but lack a neurological cause. Participants will receive either Retraining and Control Therapy (ReACT), which focuses on managing seizures through a therapist-guided plan, or the CATCH-IT program (Competent Adulthood Transition with Cognitive Behavioral, Humanistic, and Interpersonal Training), which uses online cognitive behavioral training with family involvement. The trial aims to assess the feasibility of a larger study to determine which treatment is more effective. It seeks participants aged 11-18 who have functional seizures and internet access for telehealth sessions.

As an unphased trial, this study offers participants the chance to contribute to pioneering research that could shape future treatment options for functional seizures.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, it does exclude participants who are currently in other therapy, which might suggest some restrictions on concurrent treatments.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that both the ReACT and CATCH-IT treatments are generally easy for patients to handle. ReACT improves symptoms in children and teens with functional seizures, with no significant reports of serious side effects, suggesting it is a safe option for many patients.

CATCH-IT, an online therapy, has been studied for its effectiveness in mental health issues like depression. These studies also report it as safe, with no major negative effects. Participants usually manage it well, making it a reliable choice.

Overall, various studies have demonstrated that both treatments are safe and well-tolerated, which is encouraging for those considering joining this trial.12345

Why are researchers excited about this trial?

Researchers are excited about the ReACT and CATCH-IT interventions for functional seizures because they take a unique approach compared to traditional treatments, which often involve medication. ReACT stands out by providing a structured therapy plan with personalized sessions that focus on retraining the brain to manage seizures differently, using a hands-on approach with a therapist. Meanwhile, CATCH-IT offers an innovative web-based program that incorporates cognitive behavioral therapy (CBT) modules, engaging both the parent and child in the process. This dual approach not only aims to address the psychological aspects of functional seizures but also empowers participants with practical skills to manage their symptoms effectively.

What evidence suggests that this trial's treatments could be effective for functional seizures?

Research has shown that Retraining and Control Therapy (ReACT), one of the treatments in this trial, may help treat functional seizures in children. Specifically, studies found that children who received ReACT experienced fewer seizures. This therapy teaches them new ways to think about and respond to their symptoms, which appears effective.

Regarding the CATCH-IT treatment, another option in this trial, research suggests it can support mental health through online cognitive-behavioral strategies. While it primarily aims to prevent depression, it might also help manage functional seizures by enhancing emotional well-being and coping skills. Both treatments are under study in this trial for their potential to aid young people with functional seizures.14678

Are You a Good Fit for This Trial?

This trial is for boys and girls aged 11-18 with a diagnosis of functional seizures. They must have internet access for telehealth sessions. Those with comorbid epilepsy, less than four seizures per month, severe intellectual disability, involvement in other therapies or severe mental illness are excluded.

Inclusion Criteria

Internet access for telehealth sessions and CATCH-IT
I have been diagnosed with functional seizures.

Exclusion Criteria

I have a severe intellectual disability.
You are currently receiving other treatment.
You have severe mental illness with active delusions or hallucinations.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (phone call)

Baseline

Participants and their family member/caregiver complete questionnaires and receive a functional seizure diary

1 day
1 visit (in-person)

Treatment

Participants undergo 12 therapy sessions of either ReACT or CATCH-IT, with the first session in-person and the rest via telehealth

12 weeks
1 visit (in-person), 11 visits (virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment with follow-up visits

2 months
2 visits (virtual)

Long-term Follow-up

Participants have additional follow-up visits to assess long-term outcomes

12 months
2 visits (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • CATCH-IT
  • ReACT
Trial Overview The study compares two treatments: Retraining and Control Therapy (ReACT) and CATCH-IT to see which helps manage pediatric functional seizures better. Participants will be randomly assigned to one of the treatments at three different sites over an 18-month period.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: ReACT InterventionExperimental Treatment1 Intervention
Group II: CATCH-IT InterventionActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Yale University

Collaborator

Trials
1,963
Recruited
3,046,000+

Baylor College of Medicine

Collaborator

Trials
1,044
Recruited
6,031,000+

Published Research Related to This Trial

Young adults with uncomplicated childhood-onset epilepsy (COE) show poorer functional outcomes, particularly in cognition and overall disability, compared to population norm controls, despite having similar psychosocial outcomes after 10 years.
Baseline comorbidities such as attention-deficit/hyperactivity disorder (ADHD) and academic problems significantly contribute to these functional limitations, indicating that early identification of these issues is crucial for long-term management.
Psychosocial and functional outcomes in young adults with childhood-onset epilepsy: a 10-year follow-up.Friefeld Kesselmayer, R., McMillan, T., Lee, B., et al.[2021]
In a study of 64 patients with functional seizures, 60.1% disengaged from an online CBT-based group treatment before the first session, highlighting a significant challenge in patient engagement.
Older patients were more likely to engage in the treatment, while those who disengaged cited barriers such as timing and format, preferring individual and in-person interventions, suggesting a need for tailored approaches to improve treatment access.
An evaluation of initial engagement with a virtual group-based psychological treatment for functional seizures.Jones, A., Esteban-Serna, C., Proctor, BJ., et al.[2021]
A survey of 61 Danish paediatricians revealed that most believe functional seizures (FS) have a psychogenic cause, and many feel confident in diagnosing FS based solely on observation, highlighting a need for better training and understanding of the condition.
There is a strong demand for clinical guidelines among paediatricians, as only 13% find current treatment options adequate, and collaboration with child and adolescent mental health services (CAMHS) is seen as essential for effective management, though only 23% frequently refer patients to CAMHS.
Paediatricians' attitudes to and management of functional seizures in children.Nielsen, ES., Wichaidit, BT., Østergaard, JR., et al.[2018]

Citations

Study Details | NCT05819268 | A Multi-site Feasibility ...Diagnosis of functional seizures; Internet access for telehealth sessions and CATCH-IT. Exclusion Criteria: Comorbid epilepsy; Less than 4 functional seizures ...
Effect of Internet-Based Cognitive Behavioral Humanistic and ...CATCH-IT indicates competent adulthood transition with cognitive behavioral humanistic and interpersonal training; CES-D10, Center for ...
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/24800110/
Pilot Study of Implementation of an Internet-Based Depression ...Objective: To explore the implementation of CATCH-IT (Competent Adulthood Transition with Cognitive-behavioral Humanistic and Interpersonal Training), an ...
ReACT for Functional Seizures... functional/dissociative seizures on non-seizure outcomes in adults. [2023]. 3 ... Cognitive Intervention for Epilepsy · Robotic Exoskeleton Therapy for ...
C.A.T.C.H.-I.T.Competent Adulthood Transition With ...The purpose of this study is to adapt depression prevention interventions of proven benefit to the primary care setting in a manner that would be acceptable ...
C.A.T.C.H.-I.T.Competent Adulthood Transition With Cognitive ...The purpose of this study is to adapt depression prevention interventions of proven benefit to the primary care setting in a manner that would be...
Internet-based cognitive behavioral therapy intervention for ...This study aims to assess the efficacy of Competent Adulthood Transition with Cognitive Humanistic and Interpersonal Teaching (CATCH-IT), an internet-based ...
Cognitive Behavioural Therapy in Adults with Psychogenic ...functional seizures OR pseudoseizures OR pseudo seizures OR non epileptic attack disorder) and the intervention (psychotherapeutic Treatment ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security